(VIANEWS) – PIMCO Dynamic Income Fund (PDI), John Hancock Hedged Equity & Income Fund (HEQ), Companhia Siderurgica Nacional S.A. (SID) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 PIMCO Dynamic Income Fund (PDI) 25.91 3.31% 10.21% 2022-01-02 19:13:07
2 John Hancock Hedged Equity & Income Fund (HEQ) 13.00 -0.46% 8.92% 2022-01-01 11:13:06
3 Companhia Siderurgica Nacional S.A. (SID) 4.37 -1.58% 8.41% 2022-01-03 11:07:13
4 SINOPEC Shangai Petrochemical Company, Ltd. (SHI) 22.77 2.15% 6.76% 2022-01-03 10:41:20
5 GlaxoSmithKline (GSK) 45.47 0.91% 5.41% 2022-01-14 17:57:20
6 Sumitomo Mitsui (SMFG) 7.56 0.53% 5.1% 2022-01-14 18:01:35
7 AbbVie (ABBV) 135.87 1.76% 4.54% 2022-01-14 17:53:13
8 Unum Group (UNM) 28.10 1.26% 4.51% 2022-01-14 17:48:30
9 Virtu Financial (VIRT) 28.38 0.67% 3.97% 2021-12-30 04:09:54
10 Clorox Company (CLX) 186.60 1.98% 2.76% 2022-01-14 18:05:42

Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. PIMCO Dynamic Income Fund (PDI) – Dividend Yield: 10.21%

PIMCO Dynamic Income Fund is a close ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets across the globe. It invests in multiple fixed-income sectors, including non-agency residential and commercial mortgage-backed securities and below investment-grade securities. The fund primarily invests in mortgage-backed securities, investment-grade and high-yield corporate bonds, developed and emerging markets corporate bonds, and sovereign bonds. PIMCO Dynamic Income Fund was formed on May 30, 2012 and is domiciled in the United States.

Volume

Today’s last reported volume for PIMCO Dynamic Income Fund is 2749640, 382.31% above its average volume of 570095.

PIMCO Dynamic Income Fund’s last close was $25.91, 12.91% under its 52-week high of $29.75.

PIMCO Dynamic Income Fund’s Stock Yearly Top and Bottom Value

PIMCO Dynamic Income Fund’s stock is valued at $25.91 at 16:15 EST, way under its 52-week high of $29.75 and higher than its 52-week low of $24.54.

PIMCO Dynamic Income Fund’s Moving Average

PIMCO Dynamic Income Fund’s value is below its 50-day moving average of $25.92 and under its 200-day moving average of $27.71.

More news about PIMCO Dynamic Income Fund.

2. John Hancock Hedged Equity & Income Fund (HEQ) – Dividend Yield: 8.92%

John Hancock Hedged Equity & Income Fund is a closed-ended equity mutual fund launched and managed by John Hancock Investment Management LLC. The fund is co-managed by Wellington Management Company LLP. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It invests in stocks of companies across all market capitalizations. The fund also invests through derivatives such as call options and equity futures. John Hancock Hedged Equity & Income Fund was formed on May 26, 2011 and is domiciled in the United States.

Volume

Today’s last reported volume for John Hancock Hedged Equity & Income Fund is 92132, 142.19% above its average volume of 38041.

John Hancock Hedged Equity & Income Fund’s last close was $13.00, 5.87% under its 52-week high of $13.81.

John Hancock Hedged Equity & Income Fund’s Stock Yearly Top and Bottom Value

John Hancock Hedged Equity & Income Fund’s stock is valued at $13.00 at 16:15 EST, below its 52-week high of $13.81 and way above its 52-week low of $11.13.

John Hancock Hedged Equity & Income Fund’s Moving Average

John Hancock Hedged Equity & Income Fund’s value is higher than its 50-day moving average of $12.88 and above its 200-day moving average of $12.88.

More news about John Hancock Hedged Equity & Income Fund.

3. Companhia Siderurgica Nacional S.A. (SID) – Dividend Yield: 8.41%

Companhia Siderúrgica Nacional operates as an integrated steel producer in Brazil and Latin America. The company operates in five segments: Steel, Mining, Logistics, Energy, and Cement. It offers flat steel products, such as high, medium, low carbon, micro-alloyed, and interstitial free slabs; hot-rolled products, including heavy and light-gauge hot-rolled coils and sheets; cold-rolled products comprising cold-rolled coils and sheets; galvanized products; tin mill products that consist of flat-rolled low-carbon steel coils or sheets; and profiles, channels, UPE sections, and steel sleepers for the distribution, packaging, automotive, home appliance, and construction industries. The company primarily explores for iron ore reserves at Casa de Pedra and Engenho mines located in the city of Congonhas; and limestone and dolomite at the Bocaina mine located in the city of Arcos in the state of Minas Gerais, Brazil, as well as produces tin. In addition, it operates railway and port facilities; produces and sells cement to construction material stores, home centers, concrete producers, construction companies, mortar industries, and cement artifact producers; and generates electric power from its thermoelectric co-generation and hydroelectric power plants. The company also exports its products. Companhia Siderúrgica Nacional was incorporated in 1941 and is headquartered in São Paulo, Brazil.

Volume

Today’s last reported volume for Companhia Siderurgica Nacional S.A. is 621882, 84.07% below its average volume of 3902820.

Companhia Siderurgica Nacional S.A.’s last close was $4.44, 57.02% under its 52-week high of $10.33.

Companhia Siderurgica Nacional S.A.’s Revenue

Year-on-year quarterly revenue growth grew by 17.6%, now sitting on 47.35B for the twelve trailing months.

Companhia Siderurgica Nacional S.A.’s Stock Yearly Top and Bottom Value

Companhia Siderurgica Nacional S.A.’s stock is valued at $4.37 at 16:15 EST, way below its 52-week high of $10.33 and way higher than its 52-week low of $3.56.

Companhia Siderurgica Nacional S.A.’s Moving Average

Companhia Siderurgica Nacional S.A.’s value is above its 50-day moving average of $4.16 and way below its 200-day moving average of $6.80.

More news about Companhia Siderurgica Nacional S.A..

4. SINOPEC Shangai Petrochemical Company, Ltd. (SHI) – Dividend Yield: 6.76%

Sinopec Shanghai Petrochemical Company Limited, together with its subsidiaries, manufactures and sells petrochemical products in the People's Republic of China. It operates through five segments: Synthetic Fibers, Resins and Plastics, Intermediate Petrochemicals, Petroleum Products, and Trading of Petrochemical Products. The Synthetic Fibers segment produces polyesters, acrylic fibers, and carbon fibers that are primarily used in the textile and apparel industries. The Resins and Plastics segment produces polyester chips that are used to produce polyester fibers, coating, and containers; polyethylene resins and plastics, which are used to produce insulated cables and mulching films, as well as molded products, such as housewares and toys; and polypropylene resins that are used for films and sheets, as well as molded products, such as housewares, toys, consumer electronics, and automobile parts; and PVA granules. The Intermediate Petrochemicals segment produces p-xylene, benzene, and ethylene oxide, which are used as raw materials in the production of other petrochemicals, resins, plastics, and synthetic fibers. The Petroleum Products segment operates crude oil refinery facilities used to produce refined gasoline, fuel, diesel oil, heavy oil, and liquefied petroleum gas. The Trading of Petrochemical Products segment is involved in the import and export of petrochemical products. The company was founded in 1972 and is based in Shanghai, the People's Republic of China. Sinopec Shanghai Petrochemical Company Limited is a subsidiary of China Petroleum & Chemical Corporation.

Volume

Today’s last reported volume for SINOPEC Shangai Petrochemical Company, Ltd. is 9623, 75.67% below its average volume of 39558.

SINOPEC Shangai Petrochemical Company, Ltd.’s last close was $22.75, 18.58% below its 52-week high of $27.94.

SINOPEC Shangai Petrochemical Company, Ltd.’s Revenue

Year-on-year quarterly revenue growth grew by 28.2%, now sitting on 81.61B for the twelve trailing months.

SINOPEC Shangai Petrochemical Company, Ltd.’s Stock Yearly Top and Bottom Value

SINOPEC Shangai Petrochemical Company, Ltd.’s stock is valued at $22.77 at 16:15 EST, way under its 52-week high of $27.94 and way above its 52-week low of $20.34.

SINOPEC Shangai Petrochemical Company, Ltd.’s Moving Average

SINOPEC Shangai Petrochemical Company, Ltd.’s value is under its 50-day moving average of $22.99 and below its 200-day moving average of $23.75.

More news about SINOPEC Shangai Petrochemical Company, Ltd..

5. GlaxoSmithKline (GSK) – Dividend Yield: 5.41%

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Volume

Today’s last reported volume for GlaxoSmithKline is 4040680, 0.55% above its average volume of 4018780.

GlaxoSmithKline’s last close was $45.47, 4.27% higher than its 52-week high of $43.61.

GlaxoSmithKline’s Sales

GlaxoSmithKline’s sales growth is 7.9% for the ongoing quarter and 6.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 14% and a negative 1.6%, respectively.

GlaxoSmithKline’s Revenue

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 32.43B for the twelve trailing months.

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $45.47 at 16:15 EST, above its 52-week high of $43.61.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s worth is way above its 50-day moving average of $39.98 and way above its 200-day moving average of $39.80.

Previous days news about GlaxoSmithKline

  • Watch for continued gains in shares of glaxosmithkline PLC (gsk). According to Benzinga on Friday, 14 January, "In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. ", "Shares of GlaxoSmithKline PLC (NYSE: GSK) traded today at $45.62, eclipsing its 12-month high. "

More news about GlaxoSmithKline.

6. Sumitomo Mitsui (SMFG) – Dividend Yield: 5.1%

Sumitomo Mitsui Financial Group, Inc., together with its subsidiaries, provides commercial banking, leasing, securities, consumer finance, and other services primarily in Japan. It operates through four segments: Wholesale Business Unit, Retail Business Unit, International Business Unit, and Global Markets Business Unit. The Wholesale Business Unit segment offers financing, investment management, risk hedging, and settlement services, as well as financial solutions related to mergers and acquisition, and other advisory services primarily for large-and mid-sized corporate clients; and various leasing services, including equipment, and operating and leveraged leasing. The Retail Business Unit segment offers wealth management, settlement, consumer finance, and housing loan products and services, as well as business and asset succession services to individuals and small-sized companies. The International Business Unit segment offers loans, deposits, clearing services, trade finance, project finance, loan syndication, derivatives, and cash management services; underwriting services; and leasing services related to the construction machinery, transportation equipment, industrial machinery, medical equipment, and aircraft leasing. The Global Markets Business Unit segment offers solutions through foreign exchange products, derivatives, bonds, stocks, and other marketable financial products. It also undertakes asset liability management operations. The company also offers credit card, Internet banking, system development and engineering, data processing, management consulting and economic research, and investment advisory and investment trust management services. Sumitomo Mitsui Financial Group, Inc. was founded in 2002 and is headquartered in Tokyo, Japan.

Volume

Today’s last reported volume for Sumitomo Mitsui is 2235770, 29.61% above its average volume of 1725070.

Sumitomo Mitsui’s last close was $7.56, 4.91% under its 52-week high of $7.95.

Sumitomo Mitsui’s Revenue

Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 2.97T for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sumitomo Mitsui’s stock is considered to be oversold (<=20).

Sumitomo Mitsui’s Stock Yearly Top and Bottom Value

Sumitomo Mitsui’s stock is valued at $7.56 at 16:15 EST, below its 52-week high of $7.95 and way above its 52-week low of $5.76.

Sumitomo Mitsui’s Moving Average

Sumitomo Mitsui’s worth is way higher than its 50-day moving average of $6.87 and higher than its 200-day moving average of $7.00.

More news about Sumitomo Mitsui.

7. AbbVie (ABBV) – Dividend Yield: 4.54%

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Volume

Today’s last reported volume for AbbVie is 9794420, 55.56% above its average volume of 6296090.

AbbVie’s last close was $135.87, 11.8% higher than its 52-week high of $121.53.

AbbVie’s Sales

AbbVie’s sales growth is 11.4% for the current quarter and 8.8% for the next. The company’s growth estimates for the current quarter and the next is 14.5% and 13.7%, respectively.

AbbVie’s Revenue

Year-on-year quarterly revenue growth grew by 33.9%, now sitting on 53.73B for the twelve trailing months.

AbbVie’s Stock Yearly Top and Bottom Value

AbbVie’s stock is valued at $135.87 at 16:15 EST, way above its 52-week high of $121.53.

AbbVie’s Moving Average

AbbVie’s value is way above its 50-day moving average of $110.57 and way above its 200-day moving average of $113.64.

More news about AbbVie.

8. Unum Group (UNM) – Dividend Yield: 4.51%

Unum Group, together with its subsidiaries, provides financial protection benefit solutions in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products. It also provides group pension, individual life and corporate-owned life insurance, reinsurance pools and management operations, and other products. The company sells its products primarily to employers for the benefit of employees. Unum Group sells its products through field sales personnel, independent brokers, and consultants, as well as independent contractor agency sales force. The company was founded in 1848 and is based in Chattanooga, Tennessee.

Volume

Today’s last reported volume for Unum Group is 2323060, 4.94% above its average volume of 2213670.

Unum Group’s last close was $28.10, 12.13% under its 52-week high of $31.98.

Unum Group’s Sales

Unum Group’s sales growth is a negative 2% for the present quarter and a decline by 1.1% for the next. The company’s growth estimates for the present quarter and the next is 0.8% and 8.7%, respectively.

Unum Group’s Revenue

Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 13.33B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Unum Group’s stock is considered to be oversold (<=20).

Unum Group’s Stock Yearly Top and Bottom Value

Unum Group’s stock is valued at $28.10 at 16:15 EST, way under its 52-week high of $31.98 and way above its 52-week low of $19.41.

Unum Group’s Moving Average

Unum Group’s worth is above its 50-day moving average of $26.49 and above its 200-day moving average of $27.67.

More news about Unum Group.

9. Virtu Financial (VIRT) – Dividend Yield: 3.97%

Virtu Financial, Inc., together with its subsidiaries, provides market making and liquidity services through its proprietary, multi-asset, and multi-currency technology platform to the financial markets worldwide. The company's Market Making segment principally consists of market making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Its Execution Services segment comprises agency-based trading and trading venues, which offer execution services in equities, ETFs, futures, fixed income, currencies, and commodities to institutions, banks, and broker dealers. Virtu Financial, Inc. was founded in 2008 and is headquartered in New York, New York.

Volume

Today’s last reported volume for Virtu Financial is 217044, 74.85% below its average volume of 863111.

Virtu Financial’s last close was $28.65, 11.44% under its 52-week high of $32.35.

Virtu Financial’s Sales

Virtu Financial’s sales growth is a negative 10.8% for the present quarter and a decline by 25.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 24.7% and a negative 43.2%, respectively.

Virtu Financial’s Revenue

Year-on-year quarterly revenue growth declined by 40.1%, now sitting on 2.63B for the twelve trailing months.

Virtu Financial’s Stock Yearly Top and Bottom Value

Virtu Financial’s stock is valued at $28.38 at 16:15 EST, way under its 52-week high of $32.35 and way higher than its 52-week low of $23.19.

Virtu Financial’s Moving Average

Virtu Financial’s worth is above its 50-day moving average of $27.58 and above its 200-day moving average of $27.60.

More news about Virtu Financial.

10. Clorox Company (CLX) – Dividend Yield: 2.76%

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands. It also provides grilling products under the Kingsford and Match Light brands; bags and wraps under the Glad brand; and cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands. In addition, the company offers dressings and sauces primarily under the Hidden Valley brand; water-filtration systems and filters under the Brita brand; and natural personal care products under the Burt's Bees brand. Further, it markets its products under the Ayudin, Clorinda, and Poett brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

Volume

Today’s last reported volume for Clorox Company is 1487230, 18.44% above its average volume of 1255640.

Clorox Company’s last close was $186.60, 19.26% under its 52-week high of $231.11.

The company’s growth estimates for the present quarter and the next is a negative 60.8% and a negative 42.9%, respectively.

Clorox Company’s Revenue

Year-on-year quarterly revenue growth declined by 9.1%, now sitting on 7.34B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Clorox Company’s stock is considered to be oversold (<=20).

Clorox Company’s Stock Yearly Top and Bottom Value

Clorox Company’s stock is valued at $186.60 at 16:15 EST, way below its 52-week high of $231.11 and way higher than its 52-week low of $156.23.

Clorox Company’s Moving Average

Clorox Company’s worth is way above its 50-day moving average of $165.00 and above its 200-day moving average of $175.32.

More news about Clorox Company.

LEAVE A REPLY

Please enter your comment!
Please enter your name here